Evidence-based management of bullous pemphigoid

Daniel, Benjamin S; Borradori, Luca; Hall, Russell P; Murrell, Dédée F (2011). Evidence-based management of bullous pemphigoid. Dermatologic clinics, 29(4), pp. 613-20. Philadelphia, Pa.: Elsevier 10.1016/j.det.2011.06.003

Full text not available from this repository. (Request a copy)

Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease typically affecting the elderly. Although different therapeutic regimens have been proposed, a review of the evidence is needed to aid clinicians in their decision making and management. Systemic therapies such as corticosteroids and adjuvants are effective in BP but are plagued with adverse effects, and potent topical steroids are an alternative treatment. This article reviews the evidence supporting different therapeutic options in the management of BP.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Borradori, Luca

ISSN:

0733-8635

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

17 Mar 2015 19:28

Publisher DOI:

10.1016/j.det.2011.06.003

PubMed ID:

21925006

Web of Science ID:

000295755500013

URI:

https://boris.unibe.ch/id/eprint/7052 (FactScience: 212201)

Actions (login required)

Edit item Edit item
Provide Feedback